Transcription activator-like effectors (TALEs) are important genomic tools with customizable DNA-binding motifs for locus-specifi c modifi cations. In particular, TALE nucleases or TALENs have been successfully used in the zebrafi sh model system to introduce targeted mutations via repair of double-stranded breaks (DSBs) either through nonhomologous end joining (NHEJ) or by homology-directed repair (HDR) and homology-independent repair in the presence of a donor template. Compared with other customizable nucleases, TALENs offer high binding specifi city and fewer sequence constraints in targeting the genome, with comparable mutagenic activity. Here, we describe a detailed in silico design tool for zebrafi sh genome editing for TALENs and CRISPR/Cas9 custom restriction enzymes using Mojo Hand 2.0 software.
Introduction
TALEs are naturally occurring transcription factors isolated from plant pathogen Xanthomonas [ 1 , 2 ] . Each TALE has a DNArecognizing TALE domain made up of a tract of almost identical repetitive units (33-35 amino acid residues) and a partial (or half) repeat unit at the end. Within each unit, the two repeat-variable di-residues (RVDs) are solely responsible for the binding specifi city of the unit toward a DNA nucleotide in a highly predictable fashion [ 3 , 4 ] . Commonly used RVDs include NI and NN for adenine; HD for cytosine; NK, NN, and NH for guanine; and NG for thymine [ 3 -6 ] . Because of the 1:1 RVD to nucleotide modularity of the TALE domain, it can be engineered to target almost any DNA sequence in the genome and can be fused with different functional domains including nuclease, transcription activator/repressor, and methyltransferases. TALEs represent important genomic tools for locus-specifi c modifi cations [ 7 -14 ] . In particular, TALENs have been extensively used for targeted mutations in vitro and in different model organisms [ 15 -22 ] .
Diverse methodologies have been developed to assemble the modular TALE domain, with the Golden Gate TALEN assembling method (Golden Gate TALEN Kit 2.0) being widely used because of its fl exibility, low start-up cost, and requirement of minimal, common molecular cloning reagents [ 23 ] . We previously reported the fi rst use of GoldyTALEN in targeted zebrafi sh genome editing through both NEHJ and HDR [ 8 ] . We also described a simple and highly active GoldyTALEN design with only 15 RVDs (or 14.5 TALE repeats) [ 22 ] . To further facilitate TALEN-mediated highthroughput genome editing, we subsequently developed a modifi ed Golden Gate TALEN assembling FusX system (Ma et al., manuscript in preparation). The new system increased assembling effi ciency, but shortened assembling time without affecting mutagenic activity and compatibility.
With the rapid development of novel genome engineering tools such as TALENs and CRISPR/Cas9 systems [ 24 ] , new software tools are needed to aid biologists in designing and constructing high-effi ciency reagents that can be used to make tailored changes within any model system of interest. Through a better understanding of the cell's endogenous DNA repair mechanisms, we can improve reagent design and targeting to achieve predictable outcomes. Microhomology-mediated end joining (MMEJ) appears to be a dominant repair pathway for TALEN, and RNA-guided engineered nuclease (RGEN) induced double-stranded breaks and has been used to generate predictable out-of-frame deletions and to incorporate donor DNA sequences in a highly effi cient manner [ 25 ] .
We previously presented the web-based Mojo Hand designer tool [ 26 ] . In the latest version 2.0, algorithm adheres to the same general steps that the original algorithm follows with the integration of new features including .bed fi le creation, microhomology, and out-of-frame scoring. Another major consideration was the incorporation of user-generated next-generation sequencing data in reagent design to deal with the tremendous inter-and intrastrain genetic variation during zebrafi sh genome targeting. In the current version, high-depth RNAseq datasets were integrated to simplify design and reduce time and cost through the avoidance of regions rich in single nucleotide polymorphisms (SNPs). Here, we describe a detail protocol of targeted zebrafi sh genome editing through NHEJ and HDR, respectively, using TALENs or CRISPR/Cas9 using the open access Mojo Hand 2.0 software.
Materials
1. Genomic DNA extraction buffer: 10 mM Tris-HCl, pH 8.3, 50 mM KCl.
2. 10 % Tween-20. 6. Select TALEN design with desired microhomology score above or out-of-frame score if predictable deletion through MMEJ is desirable ( see Note 8 ).
Zebrafi sh Embryo Genotyping and RFLP Assay
7. Generate BED fi le to be used in conjunction with Integrated Genomics Viewer (IGV) ( see Note 9 ).
1. Design primers to amplify the targeted locus ( see Note 10 ).
Extract genomic DNA from zebrafi sh embryos of the targeted fi sh line ( see Note 11 ):
(a) To prepare 1 mL working extraction buffer, freshly add 30 μL 10 % Tween-20, 30 μL 10 % NP-40, and 10 μL proteinase K to 950 μL genomic DNA extraction buffer.
(b) Transfer embryos to centrifuge tube and remove excess embryo water. (e) Incubate at 98 °C for 10 min to inactivate proteinase K.
Genotyping Targeted Genomic Locus
(f) Store genomic DNA at −20 °C until PCR.
(g) Typically, 5 μL of genomic DNA solution is used in 25 μL PCR.
3. PCR amplify the target locus.
Test RFLP assay:
(a) PCR with RFLP assay primers ( see Note 10 , Fig. 2 ).
(b) Digest 10 μL PCR product with appropriate restriction enzyme.
(c) Resolve digested product on 1.5 % agarose gel.
(d) PCR product should be completely digested into two correctly sized bands. (e) Centrifuge at 4 °C, 12,000 × g , for 5 min.
Confi rm sequence of the targeted locus by
(f) Remove supernatant and air-dry pellet.
(g) Resuspend pellet in 50 μL deionized water and quantify mRNA. 2. PCR amplify the target locus.
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3. Digest 10 μL PCR product with appropriate restriction enzyme, and resolve digested product on 1.5 % agarose gel (Fig. 4b ).
4. To detect a large deletion generated by two TALEN pairs, extract genomic DNA from control (uninjected) and TALENinjected embryos ( see Note 18 ) as described in Subheading 3.2 .
5. PCR amplifi es the target locus with appropriate primers ( see Note 18 , Fig. 2 ) , and resolve PCR product on agarose gel.
For loss-of-function mutagenesis using a single TALEN pair, germline transmission effi ciency correlated with TALEN mutagenic activity. Usually founder fi sh will be identifi ed within screening of ten injected fi shes when working with a moderately active TALEN (~60 % mutagenic activity in RFLP assay). In large deletion with two TALEN pairs, effi ciency is typically two-to fi vefold lower, also depending on the activity of TALEN pairs. In the case of site-directed mutagenesis through HDR, effi ciency will be ~100-fold lower, and a much larger number of injected fi sh will have to be screened. 
Examine Somatic TALEN Activity by RFLP Assay or PCR to Detect a Large Deletion
Screening of Germline Transmission for Stable Mutants
Notes
1. Any PCR reagents could be used and ready-to-use PCR master mix will be effi cient in high-throughput screening.
2. BsmBI and Esp3I are isoschizomers that have different optimum reaction temperature (55 °C and 37 °C, respectively). While it is not recommended to use in cycling reactions with T4 DNA ligase, optional predigestion with BsmBI at 55 °C will significantly enhance the effi ciency of TALEN assembly, reducing the number of blue colonies.
3. For TALENs with 15 RVDs, Sanger sequencing with TAL_F1 and TAL_R2 will typically cover all 14.5 repeat units. In case units are unread in sequencing, RVD-MM-F and RVD-MM-R primers, with sequences specifi c to RVD-8, can be used.
Mojo
Hand is available as a web service at www.talendesign. org . The site allows access to the program without the trouble of installation and with the ease of a familiar interface. Pointof-use help is available for each fi eld. The source code and spreadsheet are also available for noncommercial use with applicable license.
5.
For loss-of-function mutations , TALENs should be designed against early conserved exons after the start codon (and alternate start codon) or important functional domain(s) such that small indels will be introduced through NHEJ and resulted in frameshifting/premature termination. For deletion of a large genomic fragment with two pairs of TALENs, simply design two pairs of TALENs fl anking the genomic fragment to be deleted. For sitedirected mutagenesis through HDR, TALENs should target the site to be mutated. 6 . Templates for each system can be changed to user specifi cations. Notation for templates has been slightly changed from "." representing a non-preferential base to "N" representing any base. The default template for TALENs remains TsN*e, which constrains TAL-binding sites to an initial 5′ T bp.
7. For deletion of a large genomic fragment with two pairs of TALENs, unique restriction site in spacer for RFLP assay is not necessary since deletion can be simply detected by PCR ( see Note 5 ). However, inclusion of restriction site in the design of both TALEN pairs is recommended such that the activity of each TALEN pair can be confi rmed with RFLP assay before co-injection.
8. Microhomology-mediated end joining (MMEJ) is a Ku-and ligase IV-independent DNA repair mechanism that utilizes regions of microhomology adjacent to the site of DSB.
Because in-frame deletions can sometimes lower the efficiency of loss-of-function mutagenesis, we integrated an algorithm developed by Bae et al. [ 25 ] into Mojo Hand that calculates a microhomology score and an out-of-frame score for each binding site. The microhomology score is an aggregate of each pattern score associated with each microhomology between two and eight bases long, and the pattern score is calculated based on the length of the microhomology and deletion. Higher microhomology scores correspond with binding sites with stronger microhomologies. Out-of-frame score is the percentage of microhomology score from frameshifting microhomologies for each binding site. Predicted deletions give a list of all homologies within a binding site, with their sequences, deletion lengths, and pattern scores, and whether or not they cause frameshifts. Higher pattern scores correlate with a higher chance of any particular deletion occurring due to microhomology-mediated end joining. This prediction does not take into account deletions that occur due to NHEJ.
9. Integrated Genomics Viewer (IGV) is a tool that allows users to visualize their own genomic datasets and load tracks and other features in a variety of formats. We utilized the BED fi le format to store user designs for site-specifi c nucleases, which can then be loaded as a searchable feature within the track line of IGV. This allows users to visualize potential TALEN candidates in tandem with their own in-house next-generation sequencing datasets in an effi cient and intuitive manner. BLAT search maps each potential binding site across the genome, which allows users to visualize and avoid designs that are not unique. In addition this function can be used to avoid designs that bind within polymorphic stretches of the genome that may negatively impact cutting effi ciency. BED fi les are created by using the BLAT tool [ 27 ] to map binding sites and restriction enzymes to a genome specifi ed by the user. Current genomes supported by Mojo Hand include D. rerio and C. elegans due to current hosting limitations. A detailed specifi cation of BED fi le format is available at http://genome.ucsc. edu/FAQ/FAQformat.html#format1 .
10
. Although there is no restriction on primer design for initial genotyping purposes, primer pair can be designed such that they could also be used for RFLP assay. Typically, primers with amplicon size around 300-500 base pairs work well for RFLP assay. Avoid having the unique restriction site for RFLP assay in the middle of the amplicon, which, otherwise, would give two similar-sized digestion products diffi cult to be resolved in electrophoresis.
11.
To identify potential polymorphic region, genomic DNA can be extracted different batches of non-sibling embryos.
12. Assembling reaction works well even if component vectors varied in amounts within range. Equal volume of each vector could be mixed to simplify reaction setup even if their concentrations are different. 13 . PCR cycle can be further optimized based on the PCR reagent used.
14. An initial 10 μL half in vitro transcription reaction resuspended in 25 μL fi nal volume will typically yield mRNA at concentration around 500-1000 ng/μL, which is more than enough in most applications. 15 . Working mRNA solution should be stored in small aliquots and avoid repeated freeze-thaw. 16 . It is recommended to conduct dose-response trials within the range from 20 to 100 pg per TALEN arm such that the optimum dose can be chosen which resulted in survival of around 50 % of normally developed embryos.
17. Genomic DNA could be extracted from single embryo to examine mutagenic activity in individual embryo or from a group of fi ve or ten embryos to assay the average mutagenic activity of the TALEN.
18. For screening large genomic deletion, forward primer used to genotype TALEN pair 1 and reverse primer used TALEN pair 2 can be used together to screen for a large deletion resulting in a smaller-sized PCR product compared with the larger or absent PCR product in control. Reverse primer from pair 1 and forward primer from pair 2 can also be used together to screen for very rare "fl ipping" events where the targeted genomic fragment was excised but inversely inserted back into the genomic lesion. Since the PCR screening is only qualitative and does not refl ect mutagenic activity, genomic DNA can be extracted from a single embryo instead of a group of embryos.
19. This round of fi n biopsy is optional. However, prescreening for stable somatic mutation can signifi cantly increase the percentage of founder in the pool. Therefore, it is recommended in examples of large fragment deletion and site-directed mutagenesis, where germline transmission effi ciency is considerably lower.
20. F1 carrying desirable mutation will be selected. For example, small indels resulted in frameshifting or premature stop in case of loss-of-function mutagenesis and precisely incorporated donor sequence in site-directed mutagenesis.
